Keros Therapeutics Inc (KROS)
53.93
-0.21
(-0.39%)
USD |
NASDAQ |
Nov 21, 15:59
Keros Therapeutics Price: 53.93 for Nov. 21, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 20, 2024 | 53.53 | 54.86 | 52.64 | 54.14 | 383342.0 |
Nov 19, 2024 | 53.52 | 55.89 | 53.20 | 53.62 | 436570.0 |
Nov 18, 2024 | 56.53 | 57.01 | 53.72 | 54.01 | 566367.0 |
Nov 15, 2024 | 60.35 | 60.58 | 55.26 | 56.62 | 526789.0 |
Nov 14, 2024 | 63.04 | 63.51 | 60.28 | 60.35 | 564092.0 |
Nov 13, 2024 | 65.04 | 65.93 | 62.07 | 63.07 | 393673.0 |
Nov 12, 2024 | 67.13 | 68.64 | 64.38 | 64.88 | 547899.0 |
Nov 11, 2024 | 67.91 | 70.26 | 67.89 | 68.15 | 422580.0 |
Nov 08, 2024 | 67.22 | 68.41 | 65.54 | 67.91 | 624526.0 |
Nov 07, 2024 | 66.30 | 70.00 | 65.60 | 67.17 | 372378.0 |
Nov 06, 2024 | 65.00 | 66.99 | 63.76 | 66.45 | 535838.0 |
Nov 05, 2024 | 60.00 | 62.93 | 59.47 | 62.58 | 322659.0 |
Nov 04, 2024 | 59.63 | 61.49 | 57.53 | 59.95 | 448280.0 |
Nov 01, 2024 | 58.50 | 60.14 | 58.14 | 59.94 | 351458.0 |
Oct 31, 2024 | 59.48 | 59.60 | 57.79 | 58.04 | 507983.0 |
Oct 30, 2024 | 59.75 | 60.92 | 59.08 | 59.64 | 266405.0 |
Oct 29, 2024 | 60.72 | 60.72 | 58.98 | 60.14 | 251099.0 |
Oct 28, 2024 | 61.52 | 62.68 | 60.73 | 60.73 | 310258.0 |
Oct 25, 2024 | 60.00 | 61.87 | 59.94 | 60.76 | 258241.0 |
Oct 24, 2024 | 58.66 | 59.86 | 58.33 | 59.56 | 366465.0 |
Oct 23, 2024 | 59.09 | 60.25 | 57.95 | 57.99 | 189334.0 |
Oct 22, 2024 | 59.79 | 60.56 | 58.99 | 59.33 | 137583.0 |
Oct 21, 2024 | 60.83 | 61.22 | 59.44 | 60.30 | 266958.0 |
Oct 18, 2024 | 61.28 | 61.38 | 59.99 | 61.25 | 340419.0 |
Oct 17, 2024 | 61.78 | 62.22 | 60.58 | 61.09 | 293522.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
20.08
Minimum
Apr 08 2020
82.74
Maximum
Dec 17 2020
47.04
Average
46.94
Median
Dec 19 2022
Price Benchmarks
Eli Lilly and Co | 748.65 |
Regeneron Pharmaceuticals Inc | 744.74 |
Scholar Rock Holding Corp | 26.69 |
NovaBay Pharmaceuticals Inc | 0.681 |
Palatin Technologies Inc | 0.91 |
Price Related Metrics
PS Ratio | 2889.38 |
PEG Ratio | -1.971 |
Price to Book Value | 4.100 |
Earnings Yield | -9.66% |
Market Cap | 2.185B |
PEGY Ratio | -1.971 |